Drug Type Gene editing |
Synonyms- |
Target |
Mechanism DYSF gene stimulants(Dysferlin gene stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Limb-Girdle Muscular Dystrophy, Type 2B | Preclinical | FR | 22 Sep 2010 | |
Limb-Girdle Muscular Dystrophy, Type 2B | Preclinical | FR | 22 Sep 2010 |